SNMMI publishes appropriate use criteria for somatostatin receptor PET imaging

(Society of Nuclear Medicine and Molecular Imaging) The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for somatostatin receptor PET imaging in neuroendocrine tumors. This AUC is part of a new series developed by SNMMI in its role as a qualified provider-led entity (PLE) under the Medicare Appropriate Use Criteria Program for Advanced Diagnostic Imaging. The AUC for somatostatin receptor PET imaging addresses several clinical scenarios for ...